Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.62 - $0.86 $773 - $1,073
-1,248 Reduced 0.37%
333,250 $239,000
Q4 2023

Feb 13, 2024

SELL
$0.7 - $1.31 $12,119 - $22,681
-17,314 Reduced 4.92%
334,498 $284,000
Q3 2023

Nov 13, 2023

BUY
$1.25 - $3.0 $87 - $210
70 Added 0.02%
351,812 $481,000
Q2 2023

Aug 11, 2023

BUY
$1.73 - $2.79 $488,565 - $787,918
282,408 Added 407.32%
351,742 $886,000
Q1 2023

May 15, 2023

BUY
$1.43 - $4.24 $9,296 - $27,564
6,501 Added 10.35%
69,334 $157,000
Q3 2022

Nov 14, 2022

BUY
$1.64 - $2.48 $103,046 - $155,825
62,833 New
62,833 $124,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.